Ardena Holding NV

Ardena is a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and other complex therapies. Its integrated solutions enable innovative and complex molecules through services in nanomedicine and drug conjugates, advanced drug product development and manufacturing, solid-state chemistry, bioanalytical services, and CMC regulatory support. Ardena’s nanomedicine capabilities cover the formulation, process development, and GMP manufacturing of advanced delivery systems including lipid, polymeric, and metal nanoparticles.